Cubist Systematic Strategies, LLC Aquestive Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.01 - $6.09 $88,592 - $268,422	44,076 New	44,076 $187,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $12,927 - $30,368	12,196 New	12,196 $20,000
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $68,231 - $127,484	-29,926 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $110,426 - $190,628	29,926 New	29,926 $116,000
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $183,210 - $306,926	-39,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.12 - $9.09 $162,328 - $358,146	39,400 New	39,400 $191,000
Q1 2020 May 15, 2020	SELL	$1.54 - $6.75 $27,606 - $121,000	-17,926 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $54,853 - $157,390	17,926 New	17,926 $104,000
Q4 2018 Feb 14, 2019	SELL	$6.09 - $18.0 $20,626 - $60,966	-3,387 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $50,805 - $64,217	3,387 New	3,387 $59,000

123

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $165M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.